Rodríguez A, Socías L, Guerrero J E, Figueira J C, González N, Maraví-Poma E, Lorente L, Martín M, Albaya-Moreno A, Algora-Weber A, Vallés J, León-Gil C, Lisboa T, Balasini C, Villabón M, Pérez-Padilla R, Barahona D, Rello J
Unidad de Cuidados Intensivos, Hospital Joan XXIII, CIBER Enfermedades Respiratorias, IISPV, Tarragona, España.
Med Intensiva. 2010 Mar;34(2):87-94. doi: 10.1016/j.medin.2009.12.005. Epub 2010 Jan 12.
Pandemic Influenza A (H1N1)v infection is the first pandemic in which intensive care units (ICU) play a fundamental role. It has spread very rapidly since the first cases were diagnosed in Mexico with the subsequent spread of the virus throughout the Southern Cone and Europe during the summer season.
This study has aimed to compare the clinical presentation and outcome among the critical patients admitted to the ICU until July 31, 2009 in Spain with some series from Latin America.
Six series of critically ill patients admitted to the ICU were considered. Clinical characteristics, complications and outcome were compared between series.
Young patients (35-45 years) with viral pneumonia as a predominant ICU admission cause with severe respiratory failure and a high need of mechanical ventilation (60-100%) were affected. Obesity, pregnancy and chronic lung disease were risk factors associated with a worse outcome, however there was a high number of patients without comorbidities (40-50%). Mortality rate was between 25-50% and higher in the Latin America series, demonstrating the specific potential pathogenesis of the new virus. The use of antiviral treatment was delayed (between 3 and 6 days) and not generalized, with greater delay in Latin America in regards to Spain.
These data suggest that a more aggressive treatment strategy, with earlier and easier access to the antiviral treatment might reduce the number of ICU admissions and mortality.
甲型H1N1流感大流行感染是重症监护病房(ICU)发挥重要作用的首例大流行。自墨西哥首次确诊病例以来,该病毒传播迅速,随后在夏季蔓延至整个南锥体和欧洲。
本研究旨在比较西班牙截至2009年7月31日入住ICU的重症患者与拉丁美洲部分系列病例的临床表现和预后。
纳入6组入住ICU的重症患者系列。对各系列之间的临床特征、并发症和预后进行比较。
年轻患者(35 - 45岁)受影响,以病毒性肺炎为入住ICU的主要原因,伴有严重呼吸衰竭,对机械通气需求高(60 - 100%)。肥胖、妊娠和慢性肺病是与预后较差相关的危险因素,然而无合并症的患者数量众多(40 - 50%)。拉丁美洲系列的死亡率在25 - 50%之间且更高,表明新病毒具有特定的潜在发病机制。抗病毒治疗的使用延迟(3至6天)且未普及,拉丁美洲相对于西班牙延迟更久。
这些数据表明,采取更积极的治疗策略,更早且更易获得抗病毒治疗,可能会减少ICU入院人数和死亡率。